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Functionalized nanomaterials have an expansive range ofpotential uses in biomedical
applications. Functionalized synthetic (biocompatible and/or biodegradable) polymers
that control or monitor cell signaling can be effective antagonists and promising drug
candidates. We have developed a series ofbiodegradable functional polymer systems
(with dimensions in the nanoscale) for creating allergy-effective drugs, using RBL mast
cells and anti-2,4 dinitrophenyl (DNP) IgE antibodies that sensitize these cells by binding
to high affinity IgE receptors(FceRI); creating polymers which are effective inhibitors of
degranulation of mast cells stimulated by a potent allergen. The inhibition is possible
because ofthe specific interaction ofthe functional polymers with the proteins (IgE) on
the mast cell surfaces to control cell-signaling i.e. intelligent design of functional
materials to manipulate cellular functions. The functional polymer system is based on
biodegradable poly(lactides) carrying two, three or four 2,4-dinitrophenyl (DNP) groups.
Although these DNP-functionalized ligands do not stimulate the granule exocytosis
response, they have the potential to inhibit the robust response stimulated by other
multivalent DNP ligands. These polymeric ligands are effective inhibitors of
degranulation ofmast cells stimulated by a potent allergen and thus are a potential model
drug system. Additionally these lactide based polymers bind and achieve steady state
binding with solution IgE within a few seconds at low concentrations; achieving about
75% ofthe binding below 0.2 uM. The preparation, characterization, processing and
effectiveness ofthe functional polymers to control material-cell interactions will be
discussed
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The clustering of IgE-FceRI on mast cells surface by bivalent or multivalent
ligands controls the allergic reactions mediated by the IgE antibody. This clustering is the
key step for initiating signal transduction resulting in the granule exocytosis. There are
two Fragment antigen binding (Fab) segments that contribute to the ligand/antigen
binding with IgE. Previous studies have shown that ligands end-functionalized by DNP-
e-amino-n-caproic acid (DNP) have the ability to control the crosslinking ofanti-DNP
IgE-FceRI complex and, furthermore, the degree or activity level of crosslinking can be
controlled by the size (i.e. length), composition, and DNP valency.[1>2] Earlier studies
demonstrated that monovalent ligands, in most instances, do not stimulate mast cells
because the monovalent ligands do not result in significant crosslinking. Crosslinking by
multivalent ligands were quite effective and stimulates cell activation or degranulation.
On the other hand, certain bivalent ligands have the ability to inhibit granule exocytosis.
The inhibition or inhibitory activity is dependent on the structure ofthe bivalent ligand
and also whether the binding is intermolecular or intramolecular.[1'3] The development
ofbiodegradable polymers from renewable sources will make excellent inhibitors of cell
activation.
A large fraction ofcommon polymeric components in the market and in most
applications are produced from non-renewable fossil resources. While many synthetic
polymers can be recycled and reused, the use ofpolymers synthesized from non-
renewable sources on such a large scale has had many negative effects that have altered
the world's environment, including the change in its climate. Waste from nondegradable
polymeric solids or polymers which are not recycled and reused can generate greenhouse
gases during various steps ofprocessing raw materials, manufacturing ofproducts, waste
management etc.[4] These materials, commonly referred to as plastics are used for
building material, packing, and many other non- degradable consumables. Even with all
the drawbacks ofusing synthetic polymers, the annual production of synthetic polymers
from petroleum products in increasing. It is reported that the reserve to production ratio
for oil in the world is around 40 years. This information has increased the push to
develop polymer systems whose development does not rely on petroleum or natural gas
sources.
In addition to developing products whose production does not rely on fossil fuels,
the development ofconsumable products that degrade has become a priority. Non
degradable products end up in a landfill after a short shelf life. Even though recycling has
decreased lingering waste products, it only accounts for 30% ofthe plastics discarded
yearly.[5] Furthermore, successive melting/recasting ofthe plastics diminish the physical
properties, leaving it unfit for consumer products.[5]
Estimates by the United States Environmental Protection Agency suggest that
nearly 25% ofthe municipal land fill space is occupied by plastic and the incineration of
polymeric materials contribute significantly to carbon dioxide in the atmosphere.[6] This
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concern particularly affects Europe and Japan as there is less room for land fill than there
is in the United States. Many widely used polymers like polystyrene and
poly(vinlychloride) are made from toxic monomers. The stability ofthese polymers has
led to the commercial success ofthese hazardous polymers.[7] However, due to the
toxicity ofthe monomers used to prepare these polymers, there is a need for
environmentally friendly methods ofproducing renewable commodity plastics.
The problems associated with synthetic polymers have led to increased interest in
developing polymers that are derived from non-petrochemical sources and also has the
additional characteristic ofnatural degradation. Ideally these polymers can be made from
renewable resources and will be suitable for products with a short shelf life. Degradation
occurs in one oftwo ways. The polymers will degrade naturally from interaction with
micro-organisms such as fungi or bacteria. Or polymers will degrade via hydro lyric
degradation with the byproducts ofCO2, water, biomass, and inorganic material at the
same rate while leaving no toxic residue.[5J
1.1 Biodegradable Polymers
Biodegradable polymers continue to hold great promise for applications in
agriculture, industry, marine, biomedical, and Pharmaceuticals applications.[8] Bio-based
polymers are polymers that are made from natural resources while biodegradable
polymers can be synthesized from either natural or synthetic monomers. Bio-based
degradable plastics are defined by the American Society for Testing ofMaterials (ASTM)
and the International Standards Organization (ISO) as those polymers which can undergo
a significant change in the chemical structure under specific environmental conditions.[6]
Biodegradable plastics or polymers are those that degrade with the help of
microorganisms such as algae, fungi, and bacteria. These measurable changes effect the
mechanical and physical properties ofthe polymer.
Biodegradable aliphatic polyesters with great promise, such as poly(£-
caprolactone) (PCL), poly(lactide) (PLA), poly(glycolide) (PGA), and copolymer of
poly(lactides)/poly(glycolides) (PLGA) have been widely adopted in biomedical
applications.[9> 10] Ofthese biodegradable polymers, PLA has received significant
attention in biomedical application due to the polymers biodegradability,
biocompatibility, and non-toxic nature.
1.2 Biodegradable Polymers for drug Delivery.
The ability to develop controlled and specific interactions with biological
materials are ofgreat interest. These biospecific interactions may be utilized in
therapeutics such as specific drug delivery, and also monitoring and controlling cellular
performance. Furthermore, the possibility ofpreparing such materials from biodegradable
polymers is of significant interest because once the polymers carry out its function and
the polymer is no longer required, it would be ideal for the polymer to degrade into non-
toxic small molecules.
The established and desirable properties ofmany biodegradable polymers have
led to the belief that these polymers are excellent alternatives to both biocompatible and
nonbiocompatible polymers. Therefore, this area ofresearch has shown impressive
strides in advancement over the past 35 years and the research has resulted in well-
established synthesis, manufacturing, and processing ofthese materials.["'12] The main
advantage ofbiodegradable polymers used for drug delivery and other biological
applications (such as tissue engineering) is their reduced toxicity. This has given rise to
the use ofbiodegradable polymers in a broad range ofpractical applications that range
from packaging to advanced medical devices. Ofthe many different classes of
biodegradable polymers, linear aliphatic polyesters are particularly attractive and most
used, especially those derived from lactic acid (PLA), glycolic acid (PGA), and their
copolymers (PLGA)[11] [13](Figure 2.1). Aliphatic polyesters such as poly(L-lactide)
(PLLA), polyglycolide (PGA), poly(e-caprolactone) (PCL) and copolymers of
PLLA/PGA have been widely used for biomedical applications such as drug delivery,
pharmaceutical, and tissue-engineering applications because oftheir biodegradability,
low immunogenicity, and excellent biocompatibility.[I4]
1.3 Polymer Biospecific Binding
The synthesis, characterization and biospecific binding capacities ofmonovalent
and multivalent 2, 4-dintrophenyl(DNP) functionalized synthetic ligands has been
previously reported.11'15] DNP functionalized polyethylene glycol)s have demonstrated
the ability to react with DNP-specific IgE and either stimulate and inhibit mast cell
deganulation. Mast cells are primarily located in the mouth, nose, lungs, and digestive
tract. When a mast cell is degranulated granules rich in histamines and heparin are
released via a sequence ofbiological reactions initiated by the clustering ofhigh affinity
receptors (FceRI) on the surface ofthe mast cell. This response is mediated by the
crosslinking ofimmunoglobulin E by a specific antigen. Inhibitory and stimulatory
functions have been determined to be dependent on molecular weight and degree of
functionality ofthe polymers.[1] DNP, when attached to a polymer, provides the ability to
directly bind to the anti-DNP-IgE receptors on the surface of mast cells. Studies
previously conducted by Khan et al have shown that lower molecular weight DNP
functionalized poly(2-methoxystyrene) have the ability to specifically bind to the IgE-
FeRI receptor proteins in solution.[16] While binding was achieved, the hydrophobic
nature ofpoly(2-methoxystyrene) caused the binding constant in aqueous solution to be
dramatically lower than the water soluble DNP-PEG system. However, because the
poly(2-methoxystyrene) is hydrophobic, higher molecular weight (50,000 or higher)
polymers were electrospun to form nanofibers decorated with DNP groups on the fiber
surface. The DNP on the fiber surface can specifically bind with IgE in solution and also
IgE on surfaces ofmast cells.[17]
In the present study, the synthesis and characterization ofDNP functionalized
poly(lactide)s is reported and additionally, the binding properties ofthese polymers with
IgE and IgE on mast cell have been evaluated.
BACKGROUND
CHAPTER 2
Polylactide, also known as poly(lactic acid)(PLA), is a biodegradable polymer
which can be produced from renewable sources such as sugarcane and corn. Lactic acid
is harvested from the renewable resources and formed into a lactide via cyclic
dimerization by condensation(Fig 2.2).[18] The degradation ofPLA results in products
that are either excreted by the kidneys or eliminated as carbon dioxide and water via
metabolic pathways.1191 This efficient degradation coupled with the fact that PLA is a
renewable source has made PLA one the leading renewable source polymer systems.
Polylactide has made its way into a variety of applications in the pharmaceutical
industries, medical industries, and the plastics industry as a whole.[19~21] Among
biomedical applications, PLA is an important polymer for drug delivery and tissue
engineering. Hydrophoic drugs can be encapsulated into polylactides and delivery both
with targeted effectiveness and controlled release has been demonstrated. Controlled and
targeted drug delivery is essential for newer drugs, growth factors, and antibodies that
need to be locally delivered to induce tissue regeneration, and for these applications PLA
is proving to be an important polymer.[22>23]
2.1 History of Poly( lactides
Wallace Carothers was the first to report the synthesis ofpolylactides in the early
1900's.[24] However, the early polylactides produced had relatively low molecular
weights and poor mechanical properties. Further research by Dupont to improve on the
properties in the 1950's resulting in patented technology that allowed the production of
higher molecular weight polylactides.[25] Despite the early interest in polylactides,



























Figure 2.2 Chemical structures ofL-, D-, and meso- lactides.
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Eventually in the 1970's, the use ofpolylactides as a medical bioresorbable suture
was introduced by Ethicon.[26] This opened the door for a variety ofdrug delivery and
medical applications based on polylactide polymers. High production cost limited the
early industrial adoption ofpolylactides because the polymer was unable to compete with
the cheaper petrochemical derived resources. In 1994, Cargill and Dow launched a joint
venture that resulted in the development of technology that significantly reduced the
high production cost ofpolylactides.[27] The availability of cheaper polylactides allowed
the polymer to become more widely adopted as a renewable replacement for petroleum
derived polymers. In the following years a variety of companies have patented
technologies based on polylactide or poly(lactic acid).[27>28J
Polylactides have played an important role in many applications in
Pharmaceuticals.[29] The polymers are used as macromolecular pharmaceutical
substances, blood substituerit, auxiliary materials and excipients in the production of
macromolecular prodrugs, drug delivery systems and therapeutic systems.[30"33]
Polylactides are becoming a favored commodity product because it is renewable,
conserves energy, and degrades easily.
The molecular weight and chirality ofPLA affect its melting point, crystallinity
and mechanical strength ofthe resulting polymer. [34"36] The glass transition temperature
(Tg) ofPLA is in the range of 50-80°C and the melting temperature ranges from 130-
180°C.[34] Copolymerization of lactic acid with glycolic acids to produce PLGA is
utilized to obtain polymers with improved processability and mechanical properties.
The lactide monomer is a cyclic dimer produced by the dehydration of lactic acid.
It contains two stereocenters (Figure 2.2) and can be homopolymerized from either pure
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D (PDLA) or L (PLLA) enanitiomer. The D and L enantiomers can also be
copolymerized. Polymers made from a racemic mix of alternating D- and L- lactide
create a completely amorphous polymers, leading to a polymer with a faster degradation
rate.[37'38]. Homopolymers prepared from the enantiomeric pure D- or L- lactide have a
semi-crystalline structure and a much lower rate of degradation. Research on lactides is
often focused on the L- enantiomer since LLA is more commonly found in vivo. PLLA
is also a fairly crystalline and is also quite hybrophobic.[8] Polylactides take on one of
three froms; poly(L-lactide), poly(D-lactide), and poly(DL-lactide) and the three forms
are shown in figure 2.2.[38>39] Polymerization with L-lactide as the monomer produces
poly(L-lactide), polymerization with D-lactide produces poly(D-lactide), and
polymerization with both D-lactide and L-lactide produces poly(DL-lactide). Poly(L-
lactide) and poly(D-lactide) are both semi-crystalline and identical in properties with the
exception oftheir stereochemistry.[40]
2.2 Properties and Characteristics of PLA
Commercial PLA polymers are usually copolymers of L-lactide and D-lactide.
Optical purity, which is defined as the absolute value ofthe L%-D%, strongly affects the
properties ofthe polymer. Optically pure PLA (having all L configuration) is isotactic
and highly crystalline.^67 A decrease in the optical purity reduces the degree of
stereoregulartity and the crystallinity. It has been shown that PLA with more than 15%
D-lactide is amorphous.[27] Molecular and physical characteristics ofPLA polymers are
determined by the crystallinity, crystalline thickness, degree of chain orientation, and
spherulite size. Purity ofthe enantiomeric monomer has a strong influence on the
physical properties ofpolylactides. Poly (D-lactide) or Poly (L-lactide) hompolymers, as
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well as, the racemic DL copolymer that has either high L- or D- content have regular
structures and form a crystalline phases/domains. When PLA has more than 90% L-
lactide, it is semicrystalline. When the polymer is below 50-percent L-lactide, the
polymer is strictly amorphous. Lactide polymerization will always have at least a small
percentage ofracemization and this contributes to its amorphous phases in the polymer
matrix.[41]
The melting temperature of semicrystalline polylactide is a function ofthe
polymer stereochemistry and also the processing conditions ofthe polymers. Singh et al
reported the temperature range corresponding to properties of semicrystalline PLA
having high molecular weight. The presence of mesolactide in the polymer affects the
crystalline melting temperature and results in the depression ofthe melting
temperature.[34]
In PLA applications utilizing semicrystalline polymers, both appropriate glass
transition temperature and melting points are required. Therefore, the overall
stereochemistry ofthe PLA is most important since stereochemistry affects the overall
physical properties. Stereochemistry ofPLA is easily determined using NMR
spectroscopy.
2.3 Synthesis of PLA
2.3.1 Polycondensation
There are two primary methods for synthesizing PLAs. The first approach is the
polycondensation of lactic acid and the second approach entails the ring opening
polymerization ofthe lactide monomer. Polycondensation polymerization is a step
growth approach and is possible via an esterification reaction (Fig 2.3). PLA synthesis
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via condensation is a multi-step process. The disadvantage ofpolycondensation is its
difficulty in obtaining high molecular weight polymers due to complications with
removing impurities and the by-product, water.[42] Often the resulting polymer is brittle
and unusable unless additives are introduced to increase its chain length.[43] Other
shortcomings ofthis technique are the need for a large reactor, evaporation, recovery of
solvent and high racemization.
CH3
HO() ^i-(C—C—O-)-H ^=^ h^O—i—C4-OH + H2O
o o \
Figure 2.3 Equlibria observed during polycondensation ofLA to PLA.
2.3.2 Ring Opening polymerization
In ring opening polymerization (ROP), an addition polymerization, the terminal
end of a polymer acts as a reactive center.[44] The reactive center in a nucleophilic fashion
attacks the lactide ring resulting in ring-opening and addition ofrepeat units to the
polymer chain.[45] Each macromolecule formed generally contains one chain end
terminated with a functional group originating from the termination reaction and one
terminus end capped with a functional group originating from the initiator/421 For PLA,
the alkoxide ofa metal having d-orbitals such as aluminum or tin are considered to be
effective initiators for ring opening polymerization of lactide.[42]
Anionic ROP (Fig 2.4) of cyclic ester monomers takes place by the nucleophilic
attack ofthe negatively charged initiator. The anion attacks the carbonyl carbon atom
with acyl-oxygen scission. This results in an alkoxide species that is negatively charged
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and is counter balanced with a positive ion. While anionic ROP produces polymers with
high molecular weight, there is also extensive back biting and in some cases only low
molecular weights can be achieved,[42].[46] The back biting reactions can be minimized by
using appropriate initiators and polymerization conditions.
RO M 'O M
CH, O
H,C
Figure 2.4 Anionic Ring Opening Polymerization of lactide.
Various anionic initiators have been studied. Studies by Kricheldorf et al have
shown that initiators with higher nucloephilicity are required to efficiently initiate
Poly(lactide) synthesisJ47] Zinc salt, potassium phenoxide, and other weaker bases initiate
only at temperatures of 120°C and higher. Bulk polymerization at high temperatures
exhibit racemization ofthe polymer and is accompanied with significant back biting
reaction which interferes with polymer propagation.[39] Initiators such potassium butoxide
and n-,sec-,tert-butyl lithium rapidly initiate polymerization at low temperatures, but also
are excellent deprotonation agents. When lactides experiences deprotonation, the result is
racemization, low molecular weights, and unpredictable polymerization.[47>48] Lithium
based initiators also have concerns regarding toxicity, so some prefer to use sodium or
potassium metal ions because they are less toxic.[44]
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2.3.3 Coordination-insertion ring-opening polymerization
Coordination-insertion ring-opening polymerization has been considered the
pseudo-anionic ROP,[49] because propagation is believed to proceed by the coordination
ofthe monomer to the active species. This is followed by the insertion ofthe monomer
into the metal-oxygen bond by rearrangement of electrons.1421 The alkoxide bond formed
during the propagation steps keeps the growing chain attached to the metal. Termination
ofthe reaction occurs through hydrolysis forming a hydroxyl group.
Stannous Octoate, also known as tin (II) 2-ethlyhexanoate (Sn(Oct)2) is
commonly used as a catalyst in the bulk polymerization ROP of lactide because of its
solubility in the monomer., low rate of racemization, and good catalytic activity.[8>50]
Sn(Oct)2 as a catalyst allows greater than 90% conversion ofthe monomer to the polymer
and this coupled with racemization levels of lower than 1%, leads to the formation of
high molecular weight polymers. Sn(Oct)2 is also FDA approved as an food additive.[8'
51] Different mechanisms for coordination-complex have be presented, however it is
commonly accepted that the stannous alkoxide formed is the main catalyst in the reaction.
The presence ofwater converts the stannous alkoxide into a dormant hydroxyl which is
less reactiveJ521
2.4 Poly(ethylene glycol)
Poly(ethylene glycol) (PEG) has earned a deserving reputation as an attractive
polymer in biomedical applications. PEG is neutral, crystalline, thermoplastic polymer
that is highly soluble in aqueous solutions, PEGs aqueous properties has led to a number
ofuseful applications in biomedical, biotechnical, physiochemical and pharmaceutical
communities.[53>54]
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(PEG) is ideal for biomedical applications due to its lack oftoxicity and is also
FDA approved for being injectable in humans without adverse side effects. It is currently
used in many drug delivery and biomedical applications. The attachment ofPEG for
chemical modification ofvarious polymers to make them more stable and suitable for
pharmaceutical applications has increased in recent years.[55'56] The attachment ofPEG
to many polymers increases the water solubility of the polymer. PEG conjugation reduces
reticloendothelial (RES) clearance and recognition by the immune system, in turn
reducing degradation by proteolytic enzymes.[53] These distinguished properties ofPEG
have been explained by its chain's high mobility associated with conformational
flexibility and water binding ability.157"591
In water, PEG has a high exclusion volume, allowing the polymer to have optimal
interaction with water molecules, making it suitable material for water-based
applications. PEG's excellent hydrophyllicity is due to the double free electron pair on
the oxygen atom, and the flexibility of its linear structure. [58'60]
Poly(ethylene glycol) is solely comprised of ethylene oxide monomer. As the
molecular weight ofPEG increases, the viscosity increases as well. When PEG has a
molecular weight ofbelow 800, it is fluid like. When the molecular weight (MW) range
reaches between 800-1500, the consistency becomes more like petroleum jelly. From
MW of2000-6000 PEG is waxy. Once the MW reaches 20000 and above, PEG is brittle
and crystalline at room temperature. PEG had good solubility in water; however,
solubility decreases as MW increases.
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2.5 Copolymers
PLA and its copolymers suffer from some disadvantages and these include strong
hydrophobicity, poor cell affinity, high crystallinity, and difficultly in controlling the
polymer degradation.[22'61] Polyethylene glycol) (PEG) has received great attention for
its hydrophilicity and water solubility compared to most polyethers.[1'62] In order to
increase hydrophilicity and decrease crystallinity, PLLA is often copolymerized with
more amorphous and hydrophilic polymers such as PEG. PEG has gained much notoriety
for its exceptional physiochemical and biological properties which include hydrophilicity,
water solubility and lack oftoxicity.[63] The terminal hydroxyl ofPEG is readily reactive
with a variety ofcompounds.
Amphiphilic block copolymers containing covalently bound hydrophilic and
hydrophobic blocks have been materials ofgreat interest in the development of
nanomaterials in biomedicine and biotechnology.[64] Copolymerization is used to alter
the crystallinity and hydrophillicity, and the processabilty of degradable polymers.[9]
2.6 Biodegradable Block Copolymer
ABA copolymers of lactide and poly(ethylene glycol) have been previously
synthesized as a potential biodegradable polymers, but have not been functionalized in
order to achieve specific binding. Previous block copolymers using PLA and PEG have
been used as compatibilizers and precursor polymers for the synthesis ofbiodegradable
elastomers and thermosets.[8>65'66]
Biodegradable polymers are defined as having the ability to be converted into
carbon dioxide under microbial, hydrolytic, photodegradable, or oxidative degradation;
the ability to disintegrate via fragmentation and a visible loss ofmass ofthe product in
the final compost, and the absence ofnegative effects in the final compost according to
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industrial standard EN13432.[6] These actions are reflected in decrease in molecular
weight ofthe polymer as the polymer degrades, disappearance of crystalline regions
within the polymer, and diminished physical properties. Biodegradation is controlled by
either microorganisms like bacteria and fungi, or by enzymes in vitro or hydrolyitic
conditions.
Polycaprolactone, aliphatic copolyesters, aromatic copolyesters,
poly(vinylalcohol), and aliphatic polyesters are some ofthe more common biodegradable
polymers. Aliphatic polyesters are well-known bioresorbable polymers which can
possibly replace nondegradable bioresistant polymers in many applications.[67] The use of
nondegradable polymers produces an increasing amount ofwaste that has long been an
ecological problem.[68] Furthermore nondegradable polymers are generally produced
from nonrenewable resources such as crude oil and natural gas.[22'68] Linear aliphatic
polyesters are the most used biodegradable polymers with the majority ofthe attention
focused on polymers derived from lactic acid, glycolic acid and their copolymers.
The polylactides are both biodegradable and bioassimilable. PLA hydrolysis in
physiological environments produces lactic acid and glycolyic acid. Both ofwhich are
nontoxic and eliminated via the Krebs Cycle as water and carbon dioxide. Lactic acid can
be collected by fermentation ofrenewable resources such as corn and sugar beets.[68]
2.7 DNP mediated receptor clustering
Ligand-mediated receptor clusterings that modify intracellular signaling are
prevalent in nature.1151 In depth immunological studies on the activation ofthe cell
signaling, causing the allergic response and inflammation have been done.[69] This
receptor clustering can be observed in processes from viral entry into a host cell to
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antigen induced stimulation of signal transduction in host immune response.[1> 15] More
specifically, the phosphorylation ofthe receptor in active mast cells is initiated by the
antigen induced cross-linking of receptor bound anti- 2,4,-dinitrophenyl-
immunoglobulin E (IgE), which leads to the secretion of allergy and inflammation
mediators.11'15] Figure 5 provides a schematic representation ofthe important steps in the
IgE-receptor signaling leading to cell degranulation. Previously therapeutics for allergies
have focused on decreasing the effects of inflammation, vasodilation, and congestion.
However, many scientist changed direction and began to focus on targeting the molecules
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Figure 2.5. IgE mediated cell stimulation
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The production ofIgE occurs in response to the body's exposure to foreign
substances (allergens).[73'74] Once produced, IgE circulates in the body in both the free
form and bound to cell-surface receptors.[74] FceRI, a high-affinity IgE receptor, is
expressed mainly on the surface of mast cells and basophils as a multimeric complex
consisting of an a-subunit, a /3-subunit, and a disulfide-linked homodimeric y-subunit.[1'
73 ] The binding of allergens to cell surface bound IgE leads to receptor aggregation,
triggering a cascade ofevents leading to an allergic response and ultimately to the release
ofhistamine and other immune mediators[75]
Postner et al reported that the symmetrical bivalent ligand N,N0-bis-[[_-(2,4-
dinitrophenyl)amino]caproyl]-L-tyrosyl]-L-cystine ((DCT)2-cys) stably crosslinks anti-,
2,4,-dinitrophenyl- immunoglobulin E bound to high affinity receptors FceRI on the
surface ofRBL-2H3 cells(mast cells).[76] At low concentrations (DCT)2-cys binding
formed mostly cylic dimers containing two IgE-FceRI and two (DCT)-2cys, that didn't
trigger mast cell degranulation. Conversely, (DCT)2-cys at higher concentrations forms
linearly crosslinked IgE-FceRI that does activate cellular degranulation.[77]
Baird et al embarked on studies whose primary objective was to determine the
architectural features of ligands that enhance their capacity to occupy the sites of a
bivalent receptor (anti-DNP IgE ) and their capacity to inhibit binding and cellular
activation caused by an antigen that stimulates intermolecular cross-linking.[1>77] This
was achieved by the synthesis, characterization of univalent, trivalaent and multivalent
PEG polymers functionalized with DNP[1'77]. In addition Baird et al investigated the role
ofvalency and polymeric spacer length via a series ofPEG-based ligands.
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Baird et al investigated the relationship between ligands structural features and its
ability to function as inhibitors of antigen stimulated degranulation. Results ofthe
research showed that PEG based bivalent ligands will successfully bind to the IgE
complex without stimulating cellular degranulation and are 100-fold more potent than
small monovalent ligands when it comes to inhibition ofdegranulation.[1] It was also
shown by Baird and company that varying the ligand of molecular weights can used as a






(3,S)-d.s-3,6-Dimethyl-l,4-dioxane-2,5-dione: (Sigma-Aldrich, FW. Wt.
144.13; mp 92-94°C.) was recrystallized in toluene under ultra high purity
N2 gas.
Stannous Octoate
Stannous Octoate: ( Sigma-Aldrich, Mol. Wt. 405.12; d 1.251 at 25° C.)
was used as received.
Poly (Ethylene glycol)
Polyethylene glycol): (Sigma- Aldrich, Av. Mol. Wt. 2000., mp 52-54°C)
was dried in a vacuum oven for 24 hours at -634 mmHg.
Glycerol
Glycerol: ( Sigma- Aldrich, FW. 92.09; d 1.25) was azeotropically
distilled with toluene.
Pentaerythritol
Pentaerythritol: (Sigma- Aldrich, FW. 136.15, mp 253-258 °C) was dried
in a vacuum oven for 48 hours under -634mmhg pressure. Needs
correction pressure (the pressure is not correct)
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Chloroform
Chloroform: ( Sigma- Aldrich, FW. 119.38; d 1.492; bp 60.5-61.5 °C )
was used as received.
Methanol
Methanol: ( Sigma- Aldrich. FW. 32.04; d 0.791; bp 64.7 °C) was used as
received.
Toluene
Toluene: ( Sigma -Aldrich. FW. 92.14 ; d 0.865; bp 110-111 °C) was
dried over 3A molecular sieves for 48 hours before use.
DNP-e-amino-n-caproic acid ( Sigma-Aldrich. FW 297.3) was used as received.
Benzene
Benzene: (Sigma-Aldrich: ACS Reagent, >99%, FW 78.11, fp -11°C, bp
80-80.2°C/760mmHg, mp 113°C) ws used during freeze drying
Calcium Hydride
Calcium Hydride: (Sigma-Aldrich: FW 42.1, bp 600°C, mp 816°C, d 1.9)
was used to dry solvents.
Hexane
Hexane: (Sigma-Aldrich: anhydrous, 95%, FW 86.18, bp 69°) was used to
precipitate polymers.
Nitrogen (N2)
Airgas: ultra high purity, compressed, FW 28.02, fp -210°C, bp -195.8°C,
d 0.072
Airgas: refrigerated liquid, FW 28.02, fp -210°C, bp -195.8°C, d 0.072
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3.2 Procedure
3.2.1 Recrystallization of L-lactide
In a 250ml Erlenmeyer flask, L-Lactide was fully dissolved in a minimal amount
ofdry toluene over heat under UHP nitrogen gas. Once dissolved the flask was removed
from heat and allowed to cool to ambient temperature. The resulting crystals were
vacuum filtered to remove excess solvent and impurities. The crystals were dried in a
vacuum oven for 2 days under reduced pressure at 45°C. *H NMR analysis was done on
the recrystallized L-lactide to confirm the absence ofwater and toluene.
3.3.2 Synthesis of PLA
The selected alcohol Poly(ethylene glycol), glycerol, pentaerythritol) and
recrystallized L-lactide were added into a 100-ml round bottom flask containing a Teflon-
coated magnetic stirring bar. Catalytic amounts of stannous octoate was added, followed
by sealing the flask with a stop cock adapter. The flask was purged under nitrogen at 90°
C for 20 minutes in an oil bath. The flask was then sealed under vacuum and the heated
to between 135-145° C for 6 hours with stirring. Figure 3.6a shows the general
polymerization scheme.
Upon completion ofthe reaction, the flask was taken out ofthe oil bath and
allowed to cool to room temperature. The product was dissolved in chloroform and
microfiltered. The polymer was precipitated into hexanes, filtered and dried under
vacuum for 2 days. The polymers was then dried in a vacuum over under reduced








Figure 3.6 a) Coordination-Insertion ring opening polymerization scheme and b) Steglich
esterfication ofpolymers
3.2.3 Preparation of a,o> -bis[2,4-dinitrophenyl] [Poly(L-lactic add)-b-
poly(ethylene glycol)-b-poIy(L-lactic acid)]
a,m -bis[hydroxyl][Poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-lactic acid)]
were dried under vacuum for 4 hours at 50°C. To a 50 ml flask 10 ml ofdry
dichloromethane, 0.5 g (0.2mmol) ofpolymer ,0 .149 g (0.5 mmol) ofN-2,4-DNP-e-
amino caproic acid, and 0.001 g (0.02mmol) of4-(dimethylamino)pyridine (DMAP)
were added (Fig 3.6b). The solution was stirred and cooled in an ice bath to 0° while 0.62
g (0.3 mmol) ofDCC was added over a 5 min period. The solution was allowed to stir for
an additional 5 mins then removed from the ice bath, and further allowed to stir at room
temperature for 16 hours. The solution was then filtered through a fritted buchner funnel,
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and the filtrate was precipitated into hexanes. The functionalized polymer was filtered
and dried in the in the over for two days at 50°C.
3.3 Characterization
3.3.1 'H Nuclear Magnetic Resonance (NMR)
*NMR spectra were obtained using a Bruker ARX 500 NMR spectrometer with
CDCI3 as the solvent and tetramethylsilane (TMS) was used as the internal standard. The
number average molecular weights were determined by' H NMR.
3.3.2 Differential Scanning Calorimetry (DSC)
Thermal analysis was performed with a TA instruments Q2000 Differential
Scanning Calorimeter with a heating rate of 15° per minute and reported values were
obtained after quench cooling the sample. The Tg's were taken at the midpoints ofthe
heat capacity changes, the Tm's were taken at the maximum ofthe enthalpy endothermic
peaks.
3.3.3 Characterization of DNP functionalized lactides
*H NMR spectra were obtained using a Bruker Avance III 500 NMR spectrometer
in CDCI3. Number average (Mn) molecular weight was determined by end group analysis
using 'H NMR spectroscopy. TMS (tetramethylsilane) was used as internal standard.
Percent functionalization was determined from NMR analysis.
FTIR spectra were recorded on a Nicolet 51 OP FT-IR spectrometer with an
accuracy band of ± 2 cm"1. FT-IR spectra of P2MS-SO3Na samples were obtained as
KBr pellets.
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Thermal analysis was carried out with a TA Q2000 Differential Scanning
Calorimeter(DSC). The samples, between 6-9 mg, were run at a 15°C min"1 heating rate
and 5°C min"1 cooling rate. Samples underwent two heating cycles heating and one
cooling cycles in a nitrogen atmosphere.
Thermal Gravimetric Analysis (TGA) was conducted using a TA Instruments
TGA 50. Data was analyzed using TA Instruments Universal Analysis. Samples were
heated at a rate of 10° C/min from room temperature to 500°C under a nitrogen purge.
3.3.4 Dynaminc Light Scattering
Static and dynamic light scattering (DLS) was carried out on a Goniometer
system (ALV) based on a rotary disk allowing finest angular steps to be performed. The
solvent used was CHC13 with a flow rate of 1.0 mL/min at 35°C performing simultaneous
measurements of static and dynamic light scattering. DLS was also conducted using a
Zetasizer Nano (Malvern). On this instrument toluene was used at a flow rate of 1.0
mL/min at 25°C.
3.4 Protocol for sensitizing cells with a solution of IgE and DNP functionalizaed
polymers.
The first step was to calculate the necessary amount ofIgE to saturate the plated
cells. The binding data, on average, shows that there are 1.65 nM ofIgE on roughly 1
million cells. Therefore, for a flask of 10 mL and 106 cells/mL, use 7.4nM of IgE. Next
the amount ofpolymer necessary to crosslink the IgE was calculated. This concentration
was close to the K<j value. On average the polymer concentration per binding site (IgE)
estimated by the binding analysis was 0.4. The cells were then harvested Tripsin, and
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quenched with RBL media. Cells were then spun down and re-suspended in Tyrodes-
BSA (lOmL). The cells were spun one more time for a wash step, and re-suspended
again in Tyrodes-BSA (lOmL).
The calculated amount ofIgE (16mL of0.8mg/mL ofIgE stock solution) in lOmL
of 10A6 cells/mL flask was added to the solution. Test tubes were used to aliquot the cell
solution to prepare different polymer dilutions for the assay. Enough cell solution was left
over for the control wells with no polymer. The 96 well plate was plated with the
prepared cell solution mixed with IgE and polymer, 150mL in each well. For controls,
some wells with a cell solution mixed with IgE alone were plated. Incubation ofthe cells
with the polymer/IgE solution went on for lhr, sensitizing the cells. The wells were
plated with 50 mL more of a sensitive concentration ofDNP-BSA (lng/mL) and
incubated for 30mins. Once completed the inhibition assay for fluorescence detection was
performed.
3.5 Binding analysis
3.5.1 Equilibrium Binding of DNP Ligands to FTIC-IgE
The polymers affinity to bind was assessed by fluorescence quenching ofFTIC-
IgE in solution and on RBL-cells, following addition ofthe polymer under equilibrium. A
binding model was used to determine the dissociation constant.
Anti-DNP FTIC in media was used to sensitize the RBL-2H3 cells for one hour.
The RBL cells were then washed with Tyrodes-BSA solution to increase specificity and
remove excess IgE. Tyroded-BSA was used to dilute to a final concentration of 10
million cells in 2ml in an acrylic cuvette and placed into a SLM 8000 fluorimeter in time
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based acquisition mode. The solution was continually mixed with a magnetic stirrer at a
constant temperature (37° C). Excitation and emission wavelengths of FTIC were 490nm
and 520nm respectively. Varying amounts ofpolymer solution were added to the cuvette
and the binding to IgE was monitored with the decrease ofFTIC fluorescence intensity.
3.5.2 Equilibrium Binding of DNP Ligands to FITC- IgE
Equilibrium binding equations were used to determine the dissociation constant for DNP
binding to IgE. Modeling the binding at equilibrium was used to determine the hyperbolic
equation for the dissociation constant. The equilibrium binding equation to determine the
fraction ofbound sites is as follows:
L = Free ligand concentration
R = Free IgE binding sites
Rtot = Total IgE binding sites (bound to ligand + free)
Ka = Apparent association constant
f= fraction ofIgE binding sites occupied by the ligand at equilibrium
L + R <-> LR
The dissociation equilibrium constant is the ratio ofthe binding rate over the separation
rate.
= kon [LR]
a Kff [L][R] Kff d
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The fraction ofbound sites can be defined as the ratio ofthe total sites occupied over the
total sites available. After substituting in the mathematical definition for the association
constant, the equilibrium equation becomes a symmetric hyperbolic with the association
constant as the parameter.
Rtot = [R] + [LR]
f_ [LR]
1 [R] + [LR]
f = l + Ka[L]
The fluorescence titration data from the binding experiment was plotted as the
ligand concentration vs. the fraction ofbound sites, and the resulting graph was fit to the
calculated symmetric hyperbolic equation. The inverse ofthe fit parameter defined the
dissociation constant for the binding data. The K<j from all the experiments are listed in
Table 4.5.
3.6 Granule Exocytosis assay
Under sterile conditions, RBL cells were sensitized with 1 jug/ml anti-DNP IgE
and plated overnight at a density of2.5 x 105 cells in a 96-well plate, in order to measure
the granule exocytosis response triggered by multivalent DNP-BSA or DNP-
functionalized polymers. The DNP ligands along with the RBL cells were incubated
together for 1 h at 37° C and the exocytotic release ofthe granule marker 13-
hexosaminidase was used to quantify the extent of degranulation.[78]
Determining the inhibition ofdegranulation was achieved by measuring the 13-
hexaminadase release from incubating IgE-sensitized RBL cells with varying
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concentrations ofDNP- polymer for 30 min at 37° C followed by stimulation with 2





The synthesis ofthe lactide based polymers was carried out by coordination-
insertion ROP of L-lactide with stannous octoate ( Sn(Oct)2> as the catalyst.Different
alcohols were used as coinitiators in the polymerization. ROP polymerization using
Sn(Oct)2 has been shown to be an effective catalyst/initiator when dealing with cyclic
esters. Furthermore, Sn(Oct)2 is accepted as a food additive and is FDA approved for use
in pharmaceutical applications.[9'22'79> 80] The exact mechanism for the ROP with
Sn(Oct)2 is still up for debate. However, the most accepted mechanism involves the
alkoxide mechanism, where stannous octoate reacts with the OH-bearing species (i.e. the
alcohol coinitiator) to form an alkoxide which is the initiating species ofthe
polymerization.152'81] Three and four arm PLLA were synthesized using glycerol and
pentaerythritol respectively via Sn(Oct)2 catalyzed ROP. The reaction vessel was slowly
heated until the desired reaction temperature was met. All polymerizations were carried
out in bulk with continuous stirring between 130°-140° C for 6-9 hours under reduced
pressure. The melt solution turned white once the polymerization began. These
conditions allowed for high conversions ofthe monomer to the polymer. The overall
scheme is shown in Figure 3.6. Polymerizations carried out above 160° C causes the
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system to turn brown. The brown coloration at elevated temperatures is due to undesired
side reaction and decomposition ofmonomer and polymer.
The lactide to alcohol molar feed ratio determines the theoritical molecular
weight ofthe polymers.[9'80] Polyethylene glycol) [PEG] 2000 was used as a co-initiator
to synthesize the linear, difunctional PLLA (Table 1). The lactide based polymers
synthesized with PEG are the only triblock copolymers in this series ofpolymers. The
central PEG segment results in a fairly water soluble system. The triblocks were
significantly more water soluble than the star polymer systems. The use ofcombining
PEG with PLLA has been of considerable interest because its adds much needed water
solubility to PLLA.t62] In addition PEG stimulates virtually no biological response, has
high chain mobility, and steric stabilization effects makes it a desirable addition to
copolymers used in biological environments.[82"84] Star shaped polymers using glycerol
(Table 4. 2) and pentaerythritol (Table 4.3) were synthesized in order to increase the end
group concentration, and are considered to be star PLA polymers. Each series of
polymers were made with the target molecular weights of 5k, 10k, and 15k.
When using glycerol to initiate the ring opening polymerization of lactides, it is
certain that the two primary hydroxyl groups are expected to initiate, while the initiation
by the secondary hydroxyl is still debatable due to possible steric hindrance.[85] NMR can
be used to investigate whether all ofthe hydroxyl groups have been activated.
Polymerization temperatures using glycerol as a coinititiator range from 110-190°C.
It is believed that steric hindrance plays a role in end-functionalizing the hydroxyl
terminated polymer with DNP. The series ofpolymers, i.e. diblock copolymers, utilizing
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PEG was able to achieve up to 75% ftmctionalization via steglich esterfication (Table
4.1). However the star polymers prepared using glycerol (Table 4.2) and pentaerythritol
(Table 3) were only functionalized up to35% and 23%, respectively. The hydroxyl ends
of the triblock copolymers are most likely more accessible due to the increased flexibility
of the PEG central segment or block. The 3-arm and 4- arm polymer were more rigid in
that they were mostly comprised ofPLLA plus one unit ofthe initiating core.
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Table 4.1 Polymerization conditions for triblock copolymers, molecular weights and %
functionalization
l*ol\mcr Mole I iim-(hr) Icmp(V) T \pectcd M,, "0
PI \ PF(. Rallo(PLA MU Functional
PI'.(j)
IMA
5k 21:1 5 140 5k 5100 75
10k 56:1 7 140 10k 9800 72
15k 91:1 10 140 15k 14,900 70
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_. j !•_ .
5 150 5k 4900 35
10k 70:1 150 10k 9900 30
15k 104:1 10 150 15k 15,200 30
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Table 4.3 Polymerization conditions for four arm polymers, molecular weights and %
functionalization
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4.2 NMR and IR Analysis
1H NMR spectroscopy was used to determine the structures ofthe polymers
synthesized. The lactide based polymers were characterized by solution 500MHz
'HNMR. The 500MHz l H NMR spectra for the triblock copolymer (Fig 4.7) pre-DNP
functionalization showing the following resonances: 8 1.6 ppm(-CH3); 8 3.7 ppm(-CH2-
CH2-O-) and 8 5.2 ppm (-CH-).Once the triblock copolymers were functionalized with
DNP-e-amino-n-caproic acid, resonances at 8 9.2 ppm, 5 8.6 ppm, and 8 8.3 ppm
represent the two hydrogens in the meta position and the one hydrogen in the ortho
position respectively (Fig 4.9). There is a shift in the methylene peak upon the
conjugation ofthe DNP, suggesting that the DNP group may have non-covalent
interaction with PEG block.
The 3-arm polymers (Fig 4.11) synthesized around glycerol show resonances of:
8 5.2 ppm (-CH-), 8 4.4 (-CH2-), 8 3.6 ppm (-CH-), and 5 1.6 ppm (-CH3). The resonance
at 8 5.2 ppm is representative ofthe (-CH-) peak within the lactide block, while the
signal at 3.6 ppm is represents the (-CH-) in the center ofthe glycerol unit. This is
confirmed by published information as well as by studying the !H NMR ofthe glycerol
and homopolymer PLLA individually.1851 Once functionalized, the 3-arm polymers
exhibited the same DNP resonances as the triblock copolymers. The 4-arm polymers (Fig
4.13) synthesized around pentaerythritol show ' HNMR resonances of: 6 5.1 ppm (-CH-)
, 8 3.6 ppm (-CH2-), and 8 1.6 ppm (-CH3) ( Fig 4.13). Number average molecular weight
(Mn) was calculated using 'H NMR according to equations provide by Izunobi et al.[86]
The peak assignments allowed for the calculation ofthe number average molecular
weight (Mn) via numerical integration ofthe ofthe peak.[86]
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Further confirmation was obtained by running IR ofthe polymers both pre and
post DNP fiinctionalization. Prior to DNP fiinctionalization, the triblock (Fig 4.8), the
three-arm(Fig 4.10), and the 4-arm(Fig 4.12) polymers all exhibit and broad peak around
3300 cm"1 indicating the presence of-OH groups. In addition an absorption band at 1750
cm"1 confirms the presence of-O-C=O ester bonds in all ofthe polymers. Once





Figure 4.7 500 MHz l H NMR spectra of a-oo -bi[2,4-dinitrophenyl][Poly(L-lactic acid)-
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Figure 4.8 a) IR spectra of a-co -bi[2,4-dinitrophenyl][Poly(L-lactic acid)-b-
poly(ethylene glycol)-b-poly(L-lactic acid)] b) IR specta ofDNP ftinctionalized






"Figure 4.9 . 500 MHz ' H NMR spectra of a) a,co -bi[2,4-dinitrophenyl][Poly(L-lactic
acid)-b-poly(ethylene glycol)-b-poly(L-lactic acid)] (b) a,co - di-hydroxyl[Poly(L-
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Figure 4.13 500 MHz ' H NMR spectrum of a)four arm PLLA polymer in CDC13 b) DNP
functionalized four arm PLLA polymer in CDCI3
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4.3 Thermal Analysis
Thermal studies were carried out using Differential Scanning Calorimetry (DSC)
and Thermal Gravimetric Analysis (TGA). TGA experiments were carried out on all
samples under nitrogen. Two transitions can be seen for the triblock in the TGA(Fig
4.14). The first transition at slightly above 250° C is the start ofthe degradation ofthe
PLLA, and the transition is dependent on the ratio ofthe PLLA and PEG in the triblock
copolymers. The PEG breakdown starts around 350° C and higher and once again is
dependent on the composition ofthe copolymers. The triblock copolymer with MW 5K
having the lowest PLLArPEG ratio shows transition at 275° C for the degradation ofthe
PLLA. As the molecular weight increase to 10 K and 15K, and along with it the fraction
ofthe PLLA in the copolymer increases, the first transition is lowered around 240° C.
This suggest that the triblock copolymer degradation is governed by the polymer
composition. The first transition begins at 235°C, 201 °C and 187° C for the 5K, 10 K and
15K, respectively. Upon completion ofthe lactide degradation, the PEG segment then
begins to degrade at 380° C, 351°C and 343°C, again for the 5K, 10 K and 15K,
respectively. Pure PEG-2000 begins thermal degradation at 361 °C, while pure lactide
homopolymer begins degradation at 214°C, with complete degradation occurring at
524°C. Once the second transition begins, the polymer continues to degrade to almost to
completion with very little residual mass left at 500° C. Both PLA and PEG are fairly
hydroscopic, therefore even though the polymers were dried in a vacuum over prior to the
TGA studies, some initial weight loss (a few percent) is observed and this loss can be
attributed to loss ofwater molecules associated with the polymer, most likely with the
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PEG segment. TGA also confirms that the two polymers are not miscible and undergo
phase separation during heating ofthe polymer.
Thermal degradation ofboth the 3-arm (Fig 4.15) and 4 arm (Fig 4.16) PLLA
show only one transition due to the degradation of PLLA.. The degradation temperature
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Figure 4.16 TGA therrmogram for four arm PLLA star polymers as a function of
molecular weight.
53
The DSC thermograms for the triblock copolymers are shown in figure 4.17. The
Tm for the polymer of5K show a broad crystalline peak with two nodes at 18° C and 24°
C indicating that the formation oftwo crystalline regions with in the polymer. The Tm is
low compared to both pure PEG-2000 and hompolymer PLA which have Tm transitions at
51°C and 150° respectively. This is due to the loose packing of crystalline regions
between both the PEG and PLA. The amorphous affect ofPEG keeps the lactide regions
from forming tight crystalline regions, while the crystalline lactide regions prevent the
amorphous PEG from ordering. As the lactide content increases in the polymer, there is
an increase in the Tm as shown by the DSC thermograms for TBIOk and TB15k which
have Tm's of 118 °C and 141 °C respectively. Both melting peaks have nodes indicating
that there is more than one crystal size was formed during the Tc. Previous studies have
discussed how polymer miscibility is affected by polymer composition, leading to varied
crystal structure formation during crystallization. These varied crystal structures affect
the melting and crystallization thermal transitions. Also as PLA content increased, the
expression ofthe Tg decreased, as shown in comparison between TB10K and TB15k.
The Tc for TB5k, TB10K, and TB15K at 0.51°C, 78°C, and 99 °C respectively occur









Figure 4.17 DSC thermogram oftriblock PEG-PLLA
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The bimodal peaks shown in the DSC thermogram for GLY-PLA polymer series
are due to the formation of crystals ofmore than one size (Fig 4.18). This possibility
occurs when all the arms ofthe glycerol have not initiated, making the polymer a mix of
2 arm and 3 arm PLLA. The bimodal peaks are seen for all the polymer synthesized with
glycerol and pentaerythritol. As the molecular weight increase, there is a greater intensity
in the Tm peak. The 3-arm polymer shows a clearly defined glass transition, cold
crystallization, and two melting peaks at 37° C, 98°C, and 116°C and 126°C respectively.
It is seen that the maximum Tm ofthe 3-arm PLLA is lower than that ofthe triblock
copolymers. However the melt transitions peaks for the 3-arm PLLA are more clearly
defined indicating greater crystal alignment that that ofthe triblock.
The Tg for the 3-arm polymers increased and with increasing molecular weight.
The glass transition values are lower than reported values for linear homopolymer PLLA
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Figure 4.19 DSC thermogram ofPENT-PLLA series
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4.4 IgE Binding Studies by PLLA Series vs. 2-vinyanisol Ligands
Lactide based polymers have an advantage ofbeing both flexbile and
biodegradable, while exhibiting a high binding affinity to the IgE receptor complex on
mast cells;especially when compared to previously tested rigid 2-vinylanisol based
polymers(P2MS57) that were also DNP functionalized and tested for their binding
affinity to the IgE receptors on mast cells. Ofthe two systems compared, P2MS57(FIG
18b) has the highest DNP functionalization at greater than 90% while the TRBlOk (Fig.
4.22)have around 75% functionalization(Table 4.























Figure 4.20 Structure ofaTBlOk b) P2MS57
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4.5 Equilibrium Binding of DNP Ligands to FITC-IgE
Equilibrium titrataions with RBL cells sensitized with FITC-IgE were performed
in order to test the specific binding ofthe polymers with anit-DNP IgE by fitting the data
to a binding equation plotting the binding sites in solution vs the fiinctionalized polymers.
This resulted in a hyperbolic curve from which the dissociation constant (ka) was
determined.
The binding ofthese polymers was first assessed by determining the total
available binding sites with a monovalent ligand DNP-aminocaproyl-L-tyrosine (DCT)
(Fig 4.23). The initial data points were extrapolated to determine the number ofbinding
sites from the DCT binding curve.
Figure 4.21 shows the quenching data for the triblock copolymer. The data was
adjusted for volume and concentration changes, leading to the fraction ofthe binding
sites being plotted against the ligand concentration in solution. Fitting the curve to a
hyperbolic trend made it possible to find the parameter for the dissociation constant based
on equilibrium steady state binding.
Fluorescence quenching experiments carried out with DCT was used as a binding
standard in order to gain better understanding ofthe polymer binding. The experiments
were performed with the same cell stock.
Titration data from the fluorescence binding experiments was plotted as the ligand
concentration vs. the fraction ofbound sites. This resulted in a graph fit to a calculated
symmetric hyperbolic equation. Figure 4.22 shows these plots for both the P2MS-7 and
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the triblock. Table 5 summarizes the final values for the dissociation constant (Ka) ofthe
triblock, P2MS57, and DCT.
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Figure 4.21 Fluorescence quenching ofFITC-IGE in time based acquisition mode. Each
dip in the line represents an addition of ligand at a certain concentration.
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Polylactlde 3 Concentration (M)
Fraction of Bound Sites at P2MS57 Concentration
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Figure 4.22 Fluorescence binding data Fraction ofbinding sites vs concentration. A)
Triblockb)P2MS57.
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Table 4.5 Summary ofKa (nM) values in IgE solution for the TBIOK, P2MS57, and DCT















Table 4.6 Summary ofKa (nM) values in IgE on RBL cells for the TBIOK, P2MS57, and
DCT
















Extrapolation ofthe initial binding slope ofthe equilibrium binding curve to meet
the complete fraction ofbound sites was performed to further identify the binding
mechanism for Triblock and P2MS57. This works with the assumption that bivalent
binding is occurring and all ofthe polymer binding sites are initially occupied without
dissociation occurring. The concentration to which the slope was extrapolated was
compared to the total concentration ofthe IgE solution. DCT, being a well-studied
chemical, binds monovalently to IgE receptor and was used a standard to calculate the
number ofbinding sites via a fluorescence quenching experiment. This was used to
calculate both the number ofIgE binding sites in solution as well as the number of
binding sites available on the RBL mast cells, under the assumption that the DCT/binding






Figure 4.23 Total available IgE binding sites with a monovalent ligand, DNP-
aminocaproyl-L-tyrosine (DCT).
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4.6 Degranulation and Inhibition Analysis
The capacity ofthe DNP-fucntionalized polymers to excite granule exocytosis in
RBL cells was examined (Fig 4.24). Prior to testing the polymers granule exocytosis
response, the Kd ofDCT was determined to be 1.5 ± 0.7 nM with IgE attatched to cells
and 4.6 ± 1.0 nM for IgE in solution. RBL mast cells showed a less than 1% granule
exocytosis response, measured by the release of/S-hexosaminidase from the cells, when
incubated with P2MS57 polymer at various concentrations. Under similar conditions,
multivalent antigen DNP-BSA shows a granule exocytosis response of approximately
55%. Additional testing with the P2MS57 polymer looked into the polymers capacity to
inhibit granule exocytosis when stimulated by multivalent DNP-BSA. This was
accomplished by pre-incubating the P2MS57 with IgE-sensitized cells followed by
incubation with a concentration of2ng/ml ofDNP-BSA. Results showed that the IC50
inhibitory concentration (i.e. 50% inhibitory concentration of ligand) ofP2MS57 polymer
was 7±2.1 fiM (n=4)(Fig 4.25). When the concentration ofthe antigen was decreased to
a concentration of lng/ml with an incubation time of 10 minutes in order to optimize the
assay, the IC50 concentration observed was 4 /*M (Fig 4.25)
Using fluorescence quenching assay to determine the Kd for triblock binding to
IgE-FceRI on cells, the Kd was determined to be 2.8 ± 1.1 nM (n=5)(Fig 4.26a). For IgE
in solution the dissociation constant was calculated to be 4.2 ± 1.8 nM(n=4). When
comparing the dissociation constants for P2MS57 to the triblock, there is more than a
tenfold decrease in the Kd ofthe lactide based polymer in both the IgE solution as well as
the IgE-FceRI on cells. This is an indication that the triblock has a tighter binding to IgE
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than P2MS57. This is possible due to the smaller molecular weight and architecture of
the polymer.
The triblock was also shown not to initiate granule exocytosis in IgE- sensitized
RBL cells just as P2MS57 (Fig 4.24). To determine the triblock polymers ability to
inhibit DNP-BSA stimulated granule exocytosis, IC50 test were conducted. The IC50 were
determined by measuring the polymer concentration that inhibit 50% ofdegranulation
stimulated by the DNP-BSA at a concentration of2ng/ml. The triblock showed IC50
values of 123 nM, proving to bind to IgE and inhibit DNP-BSA more effiently than
P2MS57 which showed IC50 an value of4 /zM . Even though the lactide based polymer
show improvement in binding over P2MS57, neither at this time compare to the binding
efficiency ofDCT (Fig 4.26b).
Previous studies performed by Baird et al have show that the most effective
inhibitors are bivalent ligand that are capable of stable intramamolecular binding between
the two binding sites ofIgE-FceRI. However the unstable binding exhibited by P2MS57
to the receptor may be the cause for IC50 values with micromolar concentration. The
triblock show IC50 values similar to that ofDCT.
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Figure 4.27 a)TB10Kb) P2MS 57 inhibition ofdegranulation at 1 ng/ml DNP-BSA at
various time points.
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The lactide based copolymer also inhibits the granule exocytosis response
stimulated by multivalent DNP-BSA. The IC50 concentration ofthe polylactide
copolymers was between 45-50 nM after optimization of inhibition conditions as shown
in Fig 4.26a. Under similar conditions, the monovalent ligand DCT has a lower IC50
value indicating that its still the more potent in inhibiting granule exocytosis that the
polymeric ligand (Fig4.25b).
4.7 Polymer-IgE Binding Analysis
DNP functionalized polylactides have proven to bind specifically to anti-DNP IgE
immobilized on RBL mast cells. In addition to binding to IgE, the polymers did not
activate a detectable response as determined by the lack of Ca2+ mobilization, PKC
activation, or granule exocytosis.
It s believed that the polymers are binding monovalently or bivalently
intramolecularly, because there is no detectable crosslink of IgE-FceRI initiating cell
signaling. To further investigate the question of if the polymers are binding
monolvalently or bivalently, monovalent binding studies in parallel with the monovalent
ligand DCT were performed. Using DCT it is possible to gain an approximate estimate
ofthe number ofIgE binding sites available. Comparing this to the binding data ofthe
polymer made it possible to asses ifthe polymer is binding bivalently. The data indicated
that the polymers are not binding bivalenty as determined to the ratio ofpolymer/binding
sites. However, the DNP functionality was not taken into account for determining the
dissociation constants ofbivalency.
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Data obtained from the binding experiments via fluorescence titration was plotted
as the ligand concentration vs the fraction ofbound sites (Fig 4.24). The Kd values shows
that the lactide based polymer is achieving 50% binding ofthe IgE, in both solution and
attached to cells, sites in solution in the nanomolar ranges. Table 5 shows that the Kd for
these polymers was consistently less than 6nM .This is a definite improvement over the
previously studied systems developed to bind to the IgE complex.
To further identify the binding mechanism for the polylactides, the initial slope of
the equilibrium binding curve was extrapolated to meet the fullest fraction ofbound sites.
This method assumes that all the polymer binding sites are initially occupied with no
dissociation affect; therefore this binding is most likely to be bivalent. The concentration
to which this slope was extrapolated was compared to the total concentration of IgE in
solution. This number ofbinding sites was calculated from a similar fluorescence
quenching experiment with DCT. This well-studied chemical binds monovalently to IgE
receptors. The same initial slope analysis for the DCT binding experiments estimates the
number ofbinding sites (IgE) in solution under the assumption that the DCT per binding
site ratio is 1. Analysis is shown is summarized in Table 5.3. When the polymer per
binding site ratio is greater than 1, it suggest that the polymers are not binding bivalently
and have some other complex binding mechanism. Although the experiments with FITC-
IgE sensitized on cells does not show conclusively that the polylactides are binding
bivalently, this interaction is seen in the experiments with FITC-IgE in solution, where






















































Lactide based polymers with 2,3, and 4- arms were synthesized using
coordination-insertion complex polymerization. It was decided that stannous octoate
would be used as the primary catalyst due to its approval by the FDA as a food additive.
The composition and structure ofthe polymers and monomers were determined by IR
spectroscopy, NMR spectroscopy, TGA, DLS, and DSC. Functionalization ofthe
polymers with DNP-e-amino-n-caproic acid via steglich esterfication gave polymers
capable of specifically binding with anti-DNP IgE in solution and also on the surface of
RBL mast cells.
The triblock copolymers was functionalized at least 70% or higher. Because of
steric hindrance, it was not possible to functionalize the three- and the four-arm
polymers to a high degree and functionalization did not reach above 40 percent.
The biodegradable triblock copolymers (i.e. the difunctional polymer) successfully bound
to anti-DNP IgE immobilized on RBL cells. In addition the polymers did not activate a
detectible signal response as determined by the lack of stimulated Ca2+, PKC activation
or granule exocytosis. The polymers were binding intramolecularly, because there was no
detectable crosslinking ofIgE-FceRI that initiated cell signaling
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The difunctional polymer,, being the only triblock copolymer, had an advantage
ofbeing both flexible and biodegradable when compared to the previously tested
P2MS57 (polystyrene based system) polymers that are more rigid in nature. The
triblocks flexibility because ofthe middle soft poly(ethylene glycol) block most likely
contributes to its ability to bind to the IgE receptor complex at lower concentrations than
P2MS57. This is quite interesting because the biodegrabale polymers are also
significantly lower in percent functionalization compared with the P2MS57.
Overall, the difunctional polymers have biofunctional properties which are
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